Sigknow Biomedical Corporate Limited of Taipei City at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine

Sigknow Biomedical Corporate Limited

6F., No. 760, Sec. 4 Bade Rd., Songshan Dist, 10567 Taipei City
Taiwan
Telephone +886 2 27612577
Fax +886 2 27612579

This company is co-exhibitor of
TAITRA Taiwan External Trade Development Council

Hall map

MEDICA 2019 hall map (Hall 17): stand C46

Fairground map

MEDICA 2019 fairground map: Hall 17

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.14  Heart circulation diagnostics equipment

Heart circulation diagnostics equipment

About us

Company details

SIGKNOW BIOMEDICAL INDEPENDENTLY DEVELOPS WORLD LEADING DIAGNOSTIC TECHNIQUES AND TOOLS

LIFE SCIENCE AND HEART RHYTHM CARE

Founded in 2014, Sigknow Biomedical’s first product was EZYPRO® ECG Recorder—a medical grade product for 14-day long-term ECG monitoring. EZYPRO® assists doctors in confirming the diagnosis of arrhythmia, helps patients receive timely treatments, and prevents severe complications such as stroke and heart failure. EZYPRO® also helps doctors to ensure surgical efficiency after cardiac surgeries or catheter ablation.

BIG DATA AND MACHINE LEARNING

Sigknow Biomedical’s professional software team independently developed an ECG analysis software, which has been certified by the TFDA. The software is equipped with built-in algorithms to accurately identify ECG signals. By using big data analysis with AI machine learning, in combination with professionals at the ECG analysis center, the software provides accurate analysis reports that assist cardiologists in making arrhythmia diagnosis and devising precise treatment options for patients.

ELECTRONICS, HARDWARE, AND SOFTWARE

Sigknow Biomedical combines its expertise in electronics, hardware, and software to independently develop innovative diagnostic tools. The first product EZYPRO® ECG Recorder has been licensed by TFDA, and it is adopted by major medical centers. The fecal occult blood test product that is still under development has won the National Innovation Award in 2017. The product is expected to be released in 2019.

More Less